Medopad Ltd
 | |
| Private | |
| ISIN | 🆔 |
| Industry | healthcare, big data, small data, mobile, internet of things, pharma, wearables |
| Founded 📆 | 2011 |
| Founder 👔 | Dan Vahdat and Dr Rich Khatib |
| Headquarters 🏙️ | , |
Area served 🗺️ | |
| Members | |
Number of employees | |
| 🌐 Website | www |
| 📇 Address | |
| 📞 telephone | |
Medopad Ltd is a British healthcare technology company headquartered in London, UK. It also has offices in Salt Lake City, USA, and Dubai, UAE. It produces applications that integrate health data from existing hospital databases as well as wearables and securely sends it to healthcare professionals' mobile devices.[1][2]
Products[edit]
Enterprise[edit]
Medopad allows hospitals to pool their patient data into a single platform so it can be served to doctors' mobile devices in real-time.[3][4] Healthcare professionals can securely access lab results, images, clinical notes, and primary care data via iPads and other mobile devices.[5] In November 2013, Medopad became the first enterprise-class mobile health information system to receive CE approval.[6]
Some of the clinical applications that Medopad include editing patient records by voice recognition or typing, scheduling, lab results, image viewing including X-rays and CT scans, electronic support documents, taking and sending photos, video conferencing, primary records, transmitting real-time vital signs, collecting and managing demographic and contact details, Apple HealthKit integration, and arbitrage system to sort and prioritise patients, hospital admission, and access to more third party applications integrated into Medopad through the Clinical App Store.[1][7]
Carl Reynolds, head of Open Health Care UK told New Scientist that an open system that worked on multiple devices would be preferential to Medopad as it would avoid locking hospitals into a single system.[1]
Cancer[edit]
In April 2015, Medopad launched a chemotherapy application for monitoring cancer patients designed specifically for the Apple Watch.[8][9][10][11]
Investors[edit]
Some of Medopad's institutional investors are Healthbox and Sandbox Industries.[12][13][14][15][16] Lord Howard Flight and Tony Brown, Non-Executive Director of the NHS both invested individually.[17]
References[edit]
- ↑ 1.0 1.1 1.2 "NewScientist". Retrieved 16 June 2014.
- ↑ "Journal of mHealth - Real-time clinical information platform driving improved outcomes". Retrieved 30 October 2015.
- ↑ "Financial Times". Retrieved 30 October 2014.
- ↑ "BBC World News Business Edition: Medopad platform technology transforms patient care while improving efficiency and saving cost". Retrieved 30 October 2015.
- ↑ "University of Oxford's Tata Idea Idol Competition". Retrieved 17 June 2014.
- ↑ "Mobile health provider becomes first to receive CE approval". Retrieved 16 June 2014.
- ↑ "Empowering Mobile Health". Retrieved 19 June 2014.
- ↑ http://www.thejournalofmhealth.com/#!Medopad’s-Apple-Watch-Chemotherapy-App-for-Cancer-Patients-Launches-in-Hospitals-Across-the-World/cuhk/553a40ac0cf2731334ee5961
- ↑ "The Lancet Oncology". Retrieved 29 October 2015.
- ↑ "The Stack". Retrieved 29 October 2015.
- ↑ "Bedside manners: Small data from patients at home will mean big cost savings". The Economist. 30 May 2015. Retrieved 29 October 2015.
- ↑ "HealthBox". Retrieved 17 June 2013.
- ↑ "'Dragons' Den' event promotes innovation in healthcare". Retrieved 17 June 2013.
- ↑ "Company Overview". Retrieved 19 June 2014.
- ↑ "Google Glass & Medopad: Rich and Dan Tell Their Story". Retrieved 16 June 2014.
- ↑ "Sandbox Portfolio". Retrieved 16 June 2014.
- ↑ "NHS Board of Directors" (PDF). Retrieved 17 June 2014.
Further reading[edit]
- The Economist - Small data from patients at home will mean big cost savings
- Financial Times - Consumer healthcare platforms on the rise
- Mobihealthnews - Healthbox London holds demo day; Irish accelerator HealthXL launches
- Rudebaguette - A detailed breakdown of the 16 startups competing at LeWeb London
External links[edit]
This article "Medopad" is from Wikipedia. The list of its authors can be seen in its historical. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
